Silver Spring, Maryland—(ENEWSPF)—May 21, 2018 Contact: Sandy Walsh The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the[Read More…]
Science
Choosing Between Death And Deportation
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices. CALIFORNIA—(ENEWSPF)—May 21, 2018 By: Dan Gorenstein “Dear the most highly respected judge and court, I’m[Read More…]
Earthjustice Statement on the Farm “Harm” Bill
Victory: Farm bill dies in U.S. House of Representatives Washington, DC—(ENEWSPF)—May 18, 2018 Contact: Martin Hayden Today, Earthjustice’s Vice President of Policy and Legislation, Martin Hayden, released the following statement after the House voted down the Farm Bill (H.R. 2). “The House Farm Bill just deservedly landed on a big[Read More…]
Health Care Sabotage Will Increase Insurance Premiums by More Than $1,000 Next Year
Washington, D.C. —(ENEWSPF)—May 18, 2018 By: Thomas Huelskoetter Today, the Center for American Progress released a new 50-state analysis projecting the average increase in insurance premiums for a 40-year-old marketplace shopper for the 2019 plan year. The analysis accounts for both the impact of repealing the Affordable Care Act’s individual mandate[Read More…]
FDA Approves Novel Preventive Treatment for Migraine in Adults
Silver Spring, Maryland—(ENEWSPF)—May 18, 2018 Contact: Sandy Walsh The U.S. Food and Drug Administration (FDA) approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by[Read More…]
Three Firms Account for Over Half of All Medicare Part D Enrollees in 2018
Pending Mergers Would Further Consolidate the Marketplace California—(ENEWSPF)—May 17, 2018 By: Juliette Cubanski, Anthony Damico, and Tricia Neuman In 2018, three Medicare Part D plan sponsors—UnitedHealth, Humana, and CVS Health—account for more than half of the program’s 43 million Part D enrollees (55 percent) and two-thirds of all stand-alone drug plan[Read More…]
1 in 3 Swimming-related Disease Outbreaks Occur at Hotels
Crypto parasite continues to cause most outbreaks and illnesses linked to pools and water playgrounds Atlanta, GA—(ENEWSPF)—May 17, 2018 By: Michele C. Hlavsa, MPH; Bryanna L. Cikesh, MPH; Virginia A. Roberts, MSPH; Amy M. Kahler, MS; Marissa Vigar, MPH; Elizabeth D. Hilborn, DVM; Timothy J. Wade, PhD; Dawn M. Roellig,[Read More…]
FDA Approves First Non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults
Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority Silver Spring, Maryland—(ENEWSPF)—May 17, 2018 By: Michael Felberbaum The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids[Read More…]
Storm To Trigger Flood Risk In Florida And May Develop Tropically
Alex Sosnowski, Senior Meteorologist for AccuWeather.com AccuWeather-(ENEWSPF)- AccuWeather reports drenching downpours, gusty winds and strong thunderstorms from a storm that originated from the tropics will affect Florida this week. The storm only has until the middle of week to acquire some tropical characteristics, so development to a strong tropical storm[Read More…]
Study: Cannabis Use Associated with Lower Risk of Atrial Fibrillation Among Patients Hospitalized for Heart Failure
Englewood, NJ—(ENEWSPF)—May 14, 2018 Contact: Paul Armentano, NORML Deputy Director Cannabis exposure is associated with lower instances of atrial fibrillation (arrhythmia) in patients hospitalized for heart failure, according to data published in the American Journal of Cardiology. A team of investigators from Seton Hall University, the University of Alabama at[Read More…]
